Summary:
We invite you to learn more about our clinical research trial to evaluate the safety and effectiveness of an investigational medication for Type 2 Diabetes.
You could play a vital role in advancing medical research
Minimum eligibility requirements:
- Age 18 years or above
- Diagnosed with type 2 diabetes mellitus greater than or equal to 180 days
- Currently taking metformin alone OR metformin with a sodium-glucose contransporter-2 (SGLT2) inhibitor (s) for 90 days or more.
Qualified Participants May Receive:
By participating, you may:
- Gain access to investigational medication at no cost.
Contribute to the advancement of medicine and potentially more effective therapeutics.